AMNIOTICS

amniotics-logo

Amniotics is a biopharma company focusing on mesenchymal stem cells (MSC) from amniotic fluid. The company was born out of the discovery of a novel source of stem cells in full-term amniotic fluid. Based on a decade of research at the internationally recognized Lund University Stem Cell Centre and the University Hospital of Lund, the company is pioneering the harvesting and propagation of tissue specific neonatal quality mesenchymal stem cells (MSC). These stem cells have unique properties for a... pplications in regenerative medicine. Amniotics has also an, by Läkemedelsverket (MPA in Sweden), approved GMP (Good Manufacturing Practice) manufacturing facility to produce Advanced therapy medicinal products (ATMPs). With the GMP facilities operational since 2020, Amniotics is now moving into clinical trials with the leading drug candidate, PulmoStem™ and is looking to establish strategic partnerships with researchers and companies that are interested in developing stem-cell-based therapies targeting diseases with high unmet needs.

#SimilarOrganizations #People #Financial #Website #More

AMNIOTICS

Social Links:

Industry:
Biotechnology Life Science

Founded:
2015-01-01

Address:
Lund, Skane Lan, Sweden

Country:
Sweden

Website Url:
http://www.amniotics.com

Total Employee:
1+

Status:
Active

Total Funding:
20 M SEK

Technology used in webpage:
CrUX Dataset CrUX Top 10m Modular Finance


Similar Organizations

enzyvant-sciences-logo

Enzyvant Sciences

Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.

materiomics-bv-logo

Materiomics BV

Materiomics BV is a biotech company located in Enschede, The Netherlands.

Current Employees Featured

marcus-larsson_image

Marcus Larsson
Marcus Larsson CEO, Founding member, and Board member @ Amniotics
CEO, Founding member, and Board member
2015-01-01

Founder


marcus-larsson_image

Marcus Larsson

Stock Details


Company's stock symbol is NASDAQ:AMNI

Investors List

lu-innovation_image

LU Innovation

LU Innovation investment in Venture Round - Amniotics

almi-invest_image

Almi Invest

Almi Invest investment in Venture Round - Amniotics

Official Site Inspections

http://www.amniotics.com Semrush global rank: 11.63 M Semrush visits lastest month: 154

Unable to get host informations!!!

Loading ...

More informations about "Amniotics"

About us - Amniotics AB

See details»

Amniotics - Crunchbase Company Profile & Funding

Amniotics is a biopharma company focusing on mesenchymal stem cells (MSC) from amniotic fluid. The company was born out of the discovery of a novel source of stem cells in full-term …See details»

Org Chart Amniotics - The Official Board

Organizational Chart of Amniotics. Amniotics www.amniotics.com +46 723 278 520; Add an executive. Amniotics (AMNI) News . Anything missing? We search for you. Print or download . …See details»

Amniotics AB - LinkedIn

Amniotics has raised in total SEK 25m in a rights issue where Redeye acted as Sole Lead Manager and Bookrunner. Congratulations to the Amniotics AB team! Amniotics AB (publ) is a …See details»

Amniotics publishes merger document regarding the merger with …

Jul 1, 2024 Amniotics has an established GMP-facility, approved and licensed by the Swedish Medical Products Agency. The company has capabilities as a Contract Development and …See details»

Amniotics Company Profile 2024: Stock Performance & Earnings

Amniotics General Information Description. Amniotics AB is a biopharma company focusing on mesenchymal stem cells from amniotic fluid. It provides a novel platform for the production of …See details»

Amniotics - Funding, Financials, Valuation & Investors - Crunchbase

Amniotics is a biopharma company focusing on mesenchymal stem cells (MSC) from amniotic fluid. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... How …See details»

Amniotics Company Profile: Funding, Investors & Partnerships

Amniotics is a company primarily within stem cell therapeutics. We provide a novel platform for the production of medically superior mesenchymal stem cells (MSC s) including ethical and …See details»

The Swedish Companies Registration Office has authorised the ...

Sep 23, 2024 Amniotics has an established GMP-facility, approved and licensed by the Swedish Medical Products Agency. The company has capabilities as a Contract Development and …See details»

Magle Group and Amniotics merge to create a leader in high …

Jun 28, 2024 Summary of the transaction. New shares in Magle Group will be issued to Amniotics' shareholders in relation to their existing shareholdings in Amniotics with the …See details»

Amniotics: The Swedish Companies Registration Office has …

Sep 23, 2024 Amniotics has an established GMP-facility, approved and licensed by the Swedish Medical Products Agency. The company has capabilities as a Contract Development and …See details»

Amniotics - Contacts, Employees, Board Members, Advisors

Amniotics has 1 current employee profile, CEO, Founding member, and Board member Marcus Larsson. Marcus Larsson CEO, Founding member, and Board member Unlock even more …See details»

Amniotics - CoBee Company Profile & Funding Rounds

Amniotics is a biopharma company focusing on mesenchymal stem cells (MSC) from amniotic fluid. The company was born out of the discovery of a novel source of stem cells in full-term …See details»

Amniotics Statement from the Board of Directors of Amniotics …

May 30, 2024 This statement is made by the Board of Directors of Amniotics AB (publ) (the “Company” or “Amniotics”) pursuant to Section II.19 of the Swedish takeover rules f ... The …See details»

Amniotics AB (publ) Report for the fourth quarter 2023.

Feb 22, 2024 Amniotics has an established GMP-facility, approved and licensed by the Swedish Medical Products Agency. The company has capabilities as a Contract Development and …See details»

Amniotics - Company Profile - Tracxn

Nov 19, 2024 Amniotics ranks 187th among 858 active competitors. 285 of its competitors are funded while 179 have exited. Overall, Amniotics and its competitors have raised over $20.7B …See details»

Amniotics publishes 2021 Annual report - Amniotics AB

Apr 28, 2022 CEO, Amniotics AB Phone: +46 (0) 723 27 85 20 Email: [email protected]. Johny Humaloja CFO, Amniotics AB Phone: +46 (0) 73 506 6856 Email: [email protected]. …See details»

Amniotics AB | Insights

Contract Research Organization-CRO; Pharmaceuticals. Specialty Pharmaceuticals; Services; See more in Biomedtracker. Latest on Amniotics AB . Already A Biomedtracker Subscriber? …See details»

Pipeline - Amniotics AB

Pipeline. Amniotics has a project portfolio where the same technology and methodology can be applied for the various indications. We have developed methods for sorting out cells for the …See details»

linkstock.net © 2022. All rights reserved